UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016074
Receipt number R000018676
Scientific Title Pharmacy diabetes care program of self-monitoring of blood glucose: Cross-over trial
Date of disclosure of the study information 2015/02/01
Last modified on 2014/12/27 19:38:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pharmacy diabetes care program of self-monitoring of blood glucose: Cross-over trial

Acronym

COMPASS-SEP

Scientific Title

Pharmacy diabetes care program of self-monitoring of blood glucose: Cross-over trial

Scientific Title:Acronym

COMPASS-SEP

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Development of a diabetes educational program using self-monitoring blood glucose in pharmacy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

HbA1c

Key secondary outcomes

Adherence, Changes in daily eating and exercise habits


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

Self-monitoring blood glucose: 7 times a day

Interventions/Control_2

Self-monitoring blood glucose: 2 times a day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with Type 2 diabetes
higher than HbA1c 7% over 3 months

Key exclusion criteria

patients with insulin/GLP-1 therapy
kidny disease, dialyzed patient

Target sample size

14


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi OKADA

Organization

National Hospital Organization Kyoto Medical center

Division name

Department of Preventive Medicine Clinical Research Institute for Endocrine and Metabolic disease

Zip code


Address

1-1Mukaihata Fukakusa Fushimi Kyoto

TEL

075-641-9161

Email

bufobufo.ok@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi OKADA

Organization

National Hospital Organization Kyoto Medical Center

Division name

Department of Preventive Medicine Clinical Research Institute for Endocrine and Metabolic disease

Zip code


Address

1-1Mukaihata Fukakusa Fushimi Kyoto

TEL

075-641-9161

Homepage URL


Email

bufobufo.ok@gmail.com


Sponsor or person

Institute

National Hospital Organization Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

OMRON Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 12 Month 27 Day

Last modified on

2014 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018676


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name